🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hans Gelderblom

Leiden University Medical Center

ORCID: 0000-0001-9270-8636
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.1Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A prospective real‐world study of the diffuse‐type tenosynovial giant cell tumor patient journey: A 2‐year observational analysis

Journal of Surgical Oncology(2022)10.1002/jso.27067
Top 31%
0.651DataRank
Top 31%12 citations

John H. Healey, Emanuela Palmerini, Sebastian Bauer, H.W.B. Schreuder, Andreas Leithner +13 more

Papers

Driven by 10 papers — median percentile 62. Top paper: “Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors”.

Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors

The Oncologist(2020)10.1002/onco.13629
N/A
1.9DataRank · unranked
61 citations

Hans Gelderblom, Michiel A. J. van de Sande, Silvia Stacchiotti, John H. Healey, William D. Tap +10 more

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study

Orphanet Journal of Rare Diseases(2021)10.1186/s13023-021-01820-6
N/A
1.5DataRank · unranked
48 citations

Nicholas M. Bernthal, Geert Spierenburg, John H. Healey, Emanuela Palmerini, Sebastian Bauer +8 more

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2232
N/A
0.749DataRank · unranked
146 citations

Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more

A prospective real‐world study of the diffuse‐type tenosynovial giant cell tumor patient journey: A 2‐year observational analysis

Journal of Surgical Oncology(2022)10.1002/jso.27067
Top 31%
0.651DataRank
Top 31%12 citations

John H. Healey, Emanuela Palmerini, Sebastian Bauer, H.W.B. Schreuder, Andreas Leithner +13 more

Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies

The Oncologist(2023)10.1093/oncolo/oyad011
Top 46%
0.401DataRank
Top 46%10 citations

John H. Healey, Nicholas M. Bernthal, Sebastian Bauer, H.W.B. Schreuder, Andreas Leithner +10 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618
N/A
0DataRank · unranked
229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective real-world study

Research Square (Research Square)(2020)10.21203/rs.3.rs-22089/v1
N/A
0DataRank · unranked
0 citations

Geert Spierenburg, John H. Healey, Silvia Stacchiotti, Emanuela Palmerini, Sebastian Bauer +9 more

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor

CPT Pharmacometrics & Systems Pharmacology(2021)10.1002/psp4.12712
N/A
0DataRank · unranked
10 citations

Hamim Zahir, Jonathan French, Daniel Polhamus, Xiaoning Wang, Michiel A. J. van de Sande +8 more

Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors

The Journal of Clinical Pharmacology(2020)10.1002/jcph.1753
N/A
0DataRank · unranked
12 citations

Andrew J. Wagner, Jia Kang, William Knebel, Hamim Zahir, Michiel A. J. van de Sande +6 more

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

Cancer(2020)10.1002/cncr.33312
N/A
0DataRank · unranked
70 citations

Andrew J. Wagner, William D. Tap, Emanuela Palmerini, Zev A. Wainberg, Jayesh Desai +11 more